TheDaoIndex KDAO2011
2 years 10 months ago
Dr. M Tikly share #rheum challenges & solutions in South Africa:
👉⬆️training to gen. practitioners & nurses, 👉estab outreach clinics
👉lobby local government/political groups
👉use of off-label drugs
👉engage pharma: free meds/clinical trials #ACR22 #GlobalHealth @rheumnow https://t.co/BX2qXk1usN
sheila RHEUMarampa
2 years 10 months ago
Dr. Tikly discusses the solutions to drug access challenges in South Africa in both state and private sectors 👇
🔸Off label use, buyouts, price⬇️, advocacy...
Highly relatable because these are similar challenges we face in the PH @rheumarhyme @doktora_ging
#ACR22 @rheumnow https://t.co/ajshylgtIE
David Liew drdavidliew
2 years 10 months ago
Finally we're starting to get therapies for polymyalgia rheumatica!
The best of PMR therapeutics coming up at #ACR22 (and catch it all @RheumNow): https://t.co/lUPICA3Mim
Dr. John Cush RheumNow
2 years 10 months ago
#ACR22 Presents New Data on JIA Clinical Remission with Combo DMARDSs
New research being presented at #ACR22, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely to achieve clinical remission with combo DMARDSs.
https://t.co/qmfnEvDedA https://t.co/VhkYlZJG3s
Rheumatoid arthritis treatment has come leaps and bounds in recent decades. Gone are the days of gold injections, chemical synovectomies, and physician-mandated bedrest (heaven forbid). Though the marketplace for RA treatments is becoming ever more crowded, there are still unmet needs.
The updated 2022 EULAR recommendations for the management of rheumatoid arthritis (RA) were initially presented by Dr. Josef Smolen at EULAR 2022, and are now in press delineating the most recent developments and perspectives in RA treatment.
Dr. John Cush RheumNow
2 years 10 months ago
Dr. Yuz Yusof will be covering #ACR22 as a RheumNow reporter again. He'll be sharing real-time coverage on SLE, auto-inflammatory and COVID.
Follow @Yuz6Yusof! https://t.co/3rYlIrM54m
As we approach ACR22, there are many things to be excited about, especially with the reintroduction of in-person attendance. My attention this year is in research being presented in these three areas: ankylosing spondylitis; lupus management and treatment; and, subclinical RA.
Dr. John Cush RheumNow
2 years 10 months ago
Follow RheumNow reporter, Dr. Eric Dein, for real-time #ACR22 coverage! https://t.co/NZkVd2A989
Dr. John Cush RheumNow
2 years 10 months ago
Our newest RheumNow reporter, Dr. Michael Putman , will be covering SLE and Vasculitis at #ACR22 this year.
“Looking forward to seeing all my friends and colleagues in person!”-Dr. Putnam
Follow him @EBRheum for real-time coverage! https://t.co/DpFa0zwzPX
Dr. John Cush RheumNow
2 years 10 months ago
#ACR22 Will Present New Recommendations for Integrative Approach to RA Treatment
https://t.co/FI5k6LIKrO https://t.co/I0F1wJNBDc
Dr. John Cush RheumNow
2 years 10 months ago
We're excited to have Dr. Aurelia Najm back as an #ACR22 RheumNow reporter!
"I look forward to learning about developments in the field and finally meet with colleagues and collaborators from all over the world. "
-Dr. Najm
Follow @AurelieRheumo for real time #ACR22 coverage! https://t.co/o6Mhobt2BR
Dr. John Cush RheumNow
2 years 10 months ago
Dr. Robert Chao is back as a RheumNow reporter for a third year.
"I’m looking forward to the exciting hybrid format of both in person and virtual meeting this year! "
Follow @doctorRBC for real-time #ACR22 coverage! https://t.co/j6FNra7aZq
Dr. John Cush RheumNow
2 years 10 months ago
Join Dr. Jack Cush and Dr. Arthur Kavanaugh as they discuss, dissect and deliberate about data presented at the #ACR22 meeting in Philadelphia.
https://t.co/STvWZMS7xS https://t.co/oQt3ZMyjEN
Poster Hall